Balance Sheet

Assets

+39%

+53%

10Y

Currency: INR

	Mar-2002	Mar-2003	Mar-2004	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	11	816	946	11 809	15 324	13 802	12 389	3 822	4 419	5 349	4 913	20 691	43 587	94 612	104 701	115 556	74 437	35 973	27 011	64 331	50 209	57 574	92 828	113 116
Cash	11	816	946	11 809	15 324	13 802	12 389	3 822	4 419	5 349	4 913	16 224	40 565	36 862	50 808	64 504	19 283	1 659	7 908	30 004	26 769	43 702	12 199	32 970
Cash Equivalents	0	0	0	0	0	0	0	0	0	0	0	4 467	3 022	57 750	53 893	51 052	55 154	34 314	19 103	34 328	23 439	13 872	80 630	80 147
Short-Term Investments	245	0	0	0	0	0	0	12 838	658	35 261	44 061	32 324	52 132	36 655	34 094	37 955	65 333	75 854	86 654	31 302	76 961	93 903	86 080	137 213
Total Receivables	1 689	2 801	3 436	3 965	5 846	9 053	17 677	13 714	17 512	17 797	29 447	31 010	32 092	63 000	80 541	84 761	82 191	95 553	99 408	93 248	121 851	129 598	132 557	149 608
Accounts Receivables	163	209	207	238	392	423	499	964	11 748	898	20 787	24 122	22 004	50 928	67 605	71 811	78 153	88 842	94 212	91 042	105 139	114 893	113 030	131 225
Other Receivables	1 526	2 592	3 229	3 727	5 454	8 630	17 178	12 750	5 764	16 899	8 660	6 888	10 088	12 072	12 936	12 950	4 038	6 711	5 196	2 205	16 712	14 705	19 527	18 383
Inventory	1 311	1 824	2 542	3 173	5 117	6 645	7 728	9 757	10 739	15 990	22 525	26 457	32 590	56 669	64 225	68 328	68 807	78 860	78 750	93 618	92 392	109 683	102 949	107 593
Other Current Assets	0	0	0	0	234	389	1 579	2 552	2 795	1 534	1 988	4 549	26 464	37 847	15 852	22 937	25 591	24 452	24 718	21 923	7 234	7 861	7 690	18 410
Total Current Assets	3 256	5 441	6 924	18 946	26 522	29 889	39 372	42 683	36 121	75 931	102 934	115 030	186 865	288 782	299 413	329 537	316 359	310 692	316 542	304 421	348 646	398 619	434 331	525 941
PP&E Net	2 106	3 096	4 519	5 888	8 529	9 720	10 285	14 430	16 776	24 689	29 582	37 230	43 397	85 318	87 866	100 601	105 935	109 382	112 263	111 715	111 689	113 537	113 001	112 703
PP&E Gross	2 106	3 096	4 519	5 888	8 529	9 720	10 285	14 430	16 776	24 689	29 582	37 230	43 397	85 318	87 866	100 601	105 935	109 382	112 263	111 715	111 689	113 537	113 001	112 703
Accumulated Depreciation	915	1 351	1 713	1 851	3 514	4 407	5 208	6 278	8 013	16 794	20 407	24 421	28 904	33 617	47 201	49 041	57 174	67 281	79 168	90 387	100 376	116 226	125 760	135 748
Intangible Assets	470	391	410	325	448	402	755	1 767	0	2 880	3 160	3 792	4 068	11 530	36 264	48 803	51 176	63 537	63 595	56 607	61 918	93 268	87 330	90 205
Goodwill	0	0	1 612	1 538	507	697	1 729	3 253	4 060	7 720	10 218	21 078	29 123	54 846	56 347	55 362	56 067	59 558	64 815	62 876	65 913	87 127	85 690	89 394
Note Receivable	0	0	0	0	0	0	0	0	0	3 790	1 171	5 905	4 801	13 069	16 799	31 948	59 715	37 365	39 385	38 218	26 225	24 488	24 747	6 399
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	0	11 064	7 876	14 459	20 580	15 533	30 606	39 640	52 458	64 827	52 152	54 575	65 016	47 582
Other Long-Term Assets	587	41	1 804	6 512	3 628	3 203	8 647	20 502	33 763	8 723	17 676	11 727	17 579	33 596	38 034	32 319	25 305	26 764	33 467	38 004	31 536	35 821	44 883	48 782
Other Assets	0	0	1 612	1 538	507	697	1 729	3 253	4 060	7 720	10 218	21 078	29 123	54 846	56 347	55 362	56 067	59 558	64 815	62 876	65 913	87 127	85 690	89 394
Total Assets	6 419 N/A	8 969 +40%	15 268 +70%	33 209 +118%	39 634 +19%	43 910 +11%	60 788 +38%	82 635 +36%	90 721 +10%	123 731 +36%	164 740 +33%	205 827 +25%	293 708 +43%	501 601 +71%	555 303 +11%	614 102 +11%	645 164 +5%	646 938 +0%	682 525 +6%	676 667 -1%	698 078 +3%	807 436 +16%	854 997 +6%	921 006 +8%
Liabilities
Accounts Payable	376	627	925	1 063	1 110	1 504	2 393	2 543	3 194	6 453	9 918	10 580	13 283	32 430	35 829	43 954	47 662	41 479	40 937	39 737	44 898	56 815	56 533	61 843
Accrued Liabilities	0	41	17	24	33	21	18	0	166	39	36	27	19	320	439	384	336	382	94	7 383	14 833	15 127	16 889	18 856
Short-Term Debt	0	0	0	0	0	0	0	0	0	2 079	1 105	830	24 403	62 127	52 061	66 549	79 797	83 708	55 494	24 449	4 685	59 583	28 444	18 527
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	605	557	615	719	13 998	1 803	17 408	6 335	6 210	7 366	5 256	3 401	3 677	1 257	1 513
Other Current Liabilities	591	955	1 175	1 500	2 371	1 521	3 962	4 655	4 219	8 133	14 569	16 362	21 472	44 419	41 307	50 575	64 514	41 619	53 174	84 632	104 268	63 862	66 715	81 204
Total Current Liabilities	967	1 623	2 116	2 587	3 515	3 046	6 373	7 198	7 579	17 309	26 185	28 413	59 896	153 294	131 440	178 870	198 643	173 396	157 064	161 456	172 085	199 064	169 838	181 942
Long-Term Debt	2	1 263	4 130	18 230	18 747	11 144	1 436	1 789	1 712	1 573	1 554	1 153	487	13 598	31 103	14 361	17 721	15 226	20 289	8 981	4 817	5 599	3 036	3 583
Deferred Income Tax	0	291	779	923	1 140	1 555	1 178	1 228	1 209	1 348	1 552	2 054	2 757	751	1 194	3 286	2 190	1 043	581	445	319	317	1 719	2 012
Minority Interest	26	28	83	161	332	438	1 886	1 970	1 932	8 472	11 615	16 351	19 212	28 512	40 853	37 909	38 842	33 135	38 602	30 171	30 549	33 201	34 592	2 679
Other Liabilities	0	0	0	0	0	0	0	0	0	197	1 477	7 960	26 108	25 031	20 889	13 280	4 627	10 047	13 343	10 986	10 196	9 301	9 145	8 610
Total Liabilities	995 N/A	3 205 +222%	7 109 +122%	21 901 +208%	23 733 +8%	16 182 -32%	10 873 -33%	12 185 +12%	12 432 +2%	28 898 +132%	42 382 +47%	55 929 +32%	108 459 +94%	221 186 +104%	225 478 +2%	247 706 +10%	262 022 +6%	232 848 -11%	229 880 -1%	212 040 -8%	217 966 +3%	247 482 +14%	218 329 -12%	198 826 -9%
Equity
Common Stock	468	622	619	942	943	981	1 036	1 036	1 036	1 036	1 036	1 036	2 071	2 071	2 407	2 399	2 399	2 399	2 399	2 399	2 399	2 399	2 399	2 399
Retained Earnings	4 956	5 043	7 425	10 430	14 821	21 596	33 917	48 880	59 070	76 095	97 663	121 435	149 061	252 716	288 801	344 705	357 167	372 863	392 785	405 620	416 096	475 742	541 185	618 258
Additional Paid In Capital	0	0	0	0	157	5 166	15 099	15 099	15 099	15 099	15 099	15 099	14 218	18 369	18 592	11 895	11 929	11 933	11 874	11 874	11 874	11 874	11 874	11 874
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	6 923	4 082	336	1 555	1 622	216	4 286	1 623	2 150	10 245	9 755
Treasury Stock	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Equity	0	95	116	64	19	14	137	5 435	3 085	2 604	8 561	12 327	19 900	335	15 943	7 062	10 091	25 273	45 370	40 448	48 120	67 789	70 964	79 894
Total Equity	5 424 N/A	5 764 +6%	8 159 +42%	11 307 +39%	15 902 +41%	27 728 +74%	49 915 +80%	70 449 +41%	78 289 +11%	94 833 +21%	122 358 +29%	149 897 +23%	185 250 +24%	280 415 +51%	329 825 +18%	366 397 +11%	383 141 +5%	414 091 +8%	452 645 +9%	464 628 +3%	480 112 +3%	559 954 +17%	636 668 +14%	722 180 +13%
Total Liabilities & Equity	6 419 N/A	8 969 +40%	15 268 +70%	33 209 +118%	39 634 +19%	43 910 +11%	60 788 +38%	82 635 +36%	90 721 +10%	123 731 +36%	164 740 +33%	205 827 +25%	293 708 +43%	501 601 +71%	555 303 +11%	614 102 +11%	645 164 +5%	646 938 +0%	682 525 +6%	676 667 -1%	698 078 +3%	807 436 +16%	854 997 +6%	921 006 +8%
Shares Outstanding
Common Shares Outstanding	1 871	1 861	1 855	1 855	1 857	1 934	2 071	2 071	2 071	2 071	2 071	2 071	2 071	2 071	2 407	2 399	2 399	2 399	2 399	2 399	2 399	2 399	2 399	2 399
Preferred Shares Outstanding	0	157	155	14	14	14	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement Balance Sheet Cash Flow Statement

Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Balance Sheet

Balance Sheet Decomposition
Sun Pharmaceutical Industries Ltd

Balance Sheet
Sun Pharmaceutical Industries Ltd

See Also

Company

Help

Tools

Stocks

Sun Pharmaceutical Industries Ltd NSE:SUNPHARMA

Balance Sheet

Balance Sheet Decomposition Sun Pharmaceutical Industries Ltd

Balance Sheet Sun Pharmaceutical Industries Ltd

See Also

Company

Help

Tools

Stocks

Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Balance Sheet Decomposition
Sun Pharmaceutical Industries Ltd

Balance Sheet
Sun Pharmaceutical Industries Ltd